Azitra Inc.
Clinical trials sponsored by Azitra Inc., explained in plain language.
-
First-of-its-Kind skin ointment aims to treat rare genetic disease at its source
Disease control Recruiting nowThis is the first human study to test a new topical ointment, ATR12-351, designed to treat the underlying cause of Netherton Syndrome. The trial will enroll about 12 adults to check if the ointment is safe and well-tolerated when applied to skin lesions twice daily for two weeks.…
Phase: PHASE1 • Sponsor: Azitra Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New gel tested to soothe painful rash from cancer drugs
Symptom relief Recruiting nowThis study is testing a new topical gel, ATR04-484, to see if it is safe and can help treat a severe, itchy skin rash that is a common side effect of certain cancer medications (EGFR inhibitors). Adult cancer patients with this moderate-to-severe rash will apply the gel or a plac…
Phase: PHASE1, PHASE2 • Sponsor: Azitra Inc. • Aim: Symptom relief
Last updated Feb 19, 2026 14:36 UTC